Michael Steinberg

9PUBLICATIONS
67CO-AUTHORS
Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 12, 2025
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study.

Amar U Kishan, Luca F Valle, Holly Wilhalme

|Apr 07, 2025
Validation and Derivation of miRNA-Based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer.

Amar U Kishan, Kristen McGreevy, Luca Valle

|Aug 28, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

Soumyajit Roy, Tahmineh Romero, Jeff M Michalski

|Oct 21, 2022
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.

Ting Martin Ma, Yilun Sun, Shawn Malone

|Jan 21, 2022
Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT.

Nathanael Kane, Tahmineh Romero, Silvia Diaz-Perez

Pageof 2